Document is current

Any future updates will be listed below

Cost Effectiveness Analysis Rivaroxaban Plus Aspirin versus Aspirin alone in Treatment Cardiovascular Diseases: A Systematic Review

Crossref DOI link: https://doi.org/10.47176/mjiri.38.106

Published Online: 2024-10-20

Update policy: https://doi.org/10.47176/mjiri/crossmark_policy

About CrossMark